New Study Reveals Type 1 Diabetes Associated with Threefold Increase in Dementia Risk Among Older Adults

A new study in Neurology finds that older adults with Type 1 diabetes are nearly three times as likely to develop dementia compared to those without diabetes.

By: AXL Media

Published: Mar 19, 2026, 7:26 AM EDT

Source: Information for this report was sourced from American Academy of Neurology (Neurology®)

Shifting Focus to the Neurological Aging of Type 1 Patients

For decades, the primary clinical focus for Type 1 diabetes—which accounts for approximately 5% of all diabetes cases—has been on managing glycemic levels and preventing acute complications. However, as the first generation of Type 1 patients to benefit from modern insulin technology reaches age 65 and beyond, new health risks are emerging. A large-scale study involving over 280,000 participants has found a robust association between Type 1 diabetes and the onset of dementia, suggesting that the condition may influence cognitive decline more aggressively than previously understood.

Quantifying the Risk: Type 1 vs. Type 2 Diabetes

While it has long been established that Type 2 diabetes is a risk factor for cognitive impairment, this new research highlights a stark disparity. After adjusting for variables such as age and education, researchers estimated that individuals with Type 1 diabetes are nearly three times as likely to develop dementia as those without diabetes. In comparison, those with Type 2 diabetes were found to be twice as likely to develop the condition. Lead author Jennifer Weuve noted that approximately 65% of dementia cases among the Type 1 participants could be attributed directly to the underlying diabetic condition.

Analyzing the Study Cohort and Incident Rates

The study followed a diverse group of nearly 284,000 individuals with an average age of 64 over a two-year period. During this window, 2.6% of participants with Type 1 diabetes developed dementia, compared to 1.8% of those with Type 2 and only 0.6% of those without any diabetic diagnosis. While the overall number of Type 1 patients is relatively small, the high incidence rate among those surviving into their 60s and 70s underscores an urgent need for specialized neurological screening within this demographic.